Anzupgo® (delgocitinib cream) Now Available in Canada for Adult Patients Living with Moderate to Severe Chronic Hand Eczema
— Anzupgo® (delgocitinib cream) is the first topical pan-Janus kinase (JAK) treatment to be specifically indicated for adult patients living with moderate to severe chronic hand eczema (CHE) for whom topical corticosteroids are inadequate or are not advisable.i — Canada's Drug Agency (CDA-AMC) issued a positive recommendation in favour of the reimbursement of Anzupgo® (delgocitinib […]